Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1348799rdf:typepubmed:Citationlld:pubmed
pubmed-article:1348799lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:1348799lifeskim:mentionsumls-concept:C0085584lld:lifeskim
pubmed-article:1348799lifeskim:mentionsumls-concept:C0041228lld:lifeskim
pubmed-article:1348799lifeskim:mentionsumls-concept:C1302234lld:lifeskim
pubmed-article:1348799lifeskim:mentionsumls-concept:C0205332lld:lifeskim
pubmed-article:1348799pubmed:issue8799lld:pubmed
pubmed-article:1348799pubmed:dateCreated1992-5-19lld:pubmed
pubmed-article:1348799pubmed:abstractTextThe treatment of late-stage African sleeping sickness in man is often complicated by a post-treatment reactive encephalopathy. The bases of this pathological reaction was investigated in a mouse model of African trypanosomiasis. Subcurative treatment with diminazene aceturate, which did not clear parasites from the central nervous system, resulted in a post-treatment meningoencephalitis similar to that seen in man. By contrast, a curative regimen of melaminylthioarsenite and 5-nitroimidazole, which cleared parasites from the central nervous system, did not cause any pathological reaction in the mice. This result indicates that subcurative treatment leads to the development of the post-treatment encephalopathy. Evidence that this may also be the case in man was provided by the detection of trypanosome DNA with the polymerase chain reaction in the brains of 9 patients who had died as the result of a post-treatment reaction. Our findings suggest that more aggressive treatment regimens, which ensure the elimination of trypanosomes from the central nervous system, may prevent post-treatment reactions in patients.lld:pubmed
pubmed-article:1348799pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1348799pubmed:languageenglld:pubmed
pubmed-article:1348799pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1348799pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1348799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1348799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1348799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1348799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1348799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1348799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1348799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1348799pubmed:statusMEDLINElld:pubmed
pubmed-article:1348799pubmed:monthAprlld:pubmed
pubmed-article:1348799pubmed:issn0140-6736lld:pubmed
pubmed-article:1348799pubmed:authorpubmed-author:MurrayMMlld:pubmed
pubmed-article:1348799pubmed:authorpubmed-author:AdamsJ HJHlld:pubmed
pubmed-article:1348799pubmed:authorpubmed-author:JenningsF WFWlld:pubmed
pubmed-article:1348799pubmed:authorpubmed-author:KennedyP GPGlld:pubmed
pubmed-article:1348799pubmed:authorpubmed-author:HunterC ACAlld:pubmed
pubmed-article:1348799pubmed:issnTypePrintlld:pubmed
pubmed-article:1348799pubmed:day18lld:pubmed
pubmed-article:1348799pubmed:volume339lld:pubmed
pubmed-article:1348799pubmed:ownerNLMlld:pubmed
pubmed-article:1348799pubmed:authorsCompleteYlld:pubmed
pubmed-article:1348799pubmed:pagination956-8lld:pubmed
pubmed-article:1348799pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:meshHeadingpubmed-meshheading:1348799-...lld:pubmed
pubmed-article:1348799pubmed:year1992lld:pubmed
pubmed-article:1348799pubmed:articleTitleSubcurative chemotherapy and fatal post-treatment reactive encephalopathies in African trypanosomiasis.lld:pubmed
pubmed-article:1348799pubmed:affiliationDepartment of Veterinary Medicine, University of Glasgow, UK.lld:pubmed
pubmed-article:1348799pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1348799pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1348799lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1348799lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1348799lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1348799lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1348799lld:pubmed